GLP-1 agonists reduce right ventricular mitochondrial dysfunction by inhibiting the GSK3β-Drp1 signalling in pulmonary hypertension.

Eur J Med Res · 2026 · PMC12882202 · PMID 41520117

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The mPAP (mean pulmonary artery pressure) showed an increasing trend in PAB rats, which appeared to be reduced by semaglutide treatment (Supplementary Figure S1).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.